Akt
特异性亚型抑制剂
Akt产品
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S1078 |
MK-2206 2HClMK-2206 2HCl是一种高度选择性的Akt1/2/3抑制剂,在无细胞试验中IC50分别为8 nM/12 nM/65 nM;对250种其他蛋白激酶没有抑制活性。MK-2206 2HCl 在肿瘤细胞中可诱导自噬和凋亡。Phase 2。 |
![]() ![]() VE-cadherin-induced Akt activation mediates YAP phosphorylation and translocation in ECs. HUVECs were starved for 1h and treated with thrombin (1U) for 1h. Total cell lysates were probed with anti-pAkt, Akt or b-actin antibody. The representative blots of three independent experiments are depicted, and the normalized values for p-Akt are shown. HUVECs were cultured and starved as described as in d and incubated for 8h in complete medium with the Akt inhibitor, MK-2206 (1 uM). pAkt, Akt, pYAP and YAP were detected by western blotting using specific antibodies.
|
|
S1037 |
Perifosine (KRX-0401)Perifosine (KRX-0401, NSC639966)是一种新型的Akt抑制剂,在MM.1S细胞中IC50为4.7 μM,靶向作用于Akt的pleckstrin同源结构域。Phase 3。 |
![]() ![]() Tumor growth of 827 GSC-derived xenografts
treated with an AKT inhibitor perifosine (30 mg/kg
body weight). Twenty-three days after tumor
implantation in mice, perifosine was administered
by intraperitoneal injection (daily for 5 days). Error
bars represent SD. Five mice per group, *p < 0.01.
|
|
S1113 |
GSK690693GSK690693 是一种泛Akt抑制剂,靶向作用于Akt1/2/3,在无细胞试验中IC50为2 nM/13 nM/9 nM,也对AGC激酶家族:PKA,PrkX和PKC同工酶敏感。GSK690693 也能有效地抑制CAMK家族的 AMPK 和 DAPK3,对应的IC50值分别为50 nM和81 nM。GSK690693 可影响 Unc-51-like autophagy activating kinase 1 (ULK1) 的活性并有效地抑制 STING-dependent IRF3 的激活。Phase 1。 |
![]() ![]() UPN cells were treated with GSK690693 or MK2206 (1 uM) for 1h followed by LPA (10 uM), EGF or IGF-1 (10 ng/ml) for another 1h and Western blot was performed. Band intensities of phospho-AKT (p-AKTS473), phospho-S6 (p-S6S240/S244), phospho-YB-1 (p-YB-1S102) and YB-1 were quantified and normalized to the intensity of ERK2. It directly determined the role of AKT using two potent, AKT inhibitors with distinct actions—a catalytic domain inhibitor, GSK690693, and an allosteric inhibitor, MK2206 -in UPN and SKOV3 cells, which showed appreciable AKT and YB-1 phosphorylation upon growth factor stimulation. GSK690693 increased basal and growth factor-induced AKT phosphorylation due to blocking a negative feedback loop downstream of AKT, whereas MK2206 abolished both basal and growth-factor-induced AKT phosphorylation.
|
|
S1362 |
Rigosertib (ON-01910)Rigosertib (ON-01910) 是一种非ATP竞争性PLK1抑制剂,无细胞试验中IC50为9 nM,比作用于Plk2选择性高30倍,对Plk3没有抑制活性。Rigosertib 可抑制 PI3K/Akt 信号通路并激活氧化应激信号。Rigosertib 可诱导多种癌细胞的凋亡。Phase 3。 |
![]() ![]() Along with cell death, immunoblotting shows ON 01910.Na induces hyperphosphorylation of RanGAP1, increased expression of RanGAP1.SUMO1 but decreased expression of free unmodified RanGAP1. No viable SU-DHL-5 cells were available for immunoblotting at 0.5 uM of ON 01910.Na.
|
|
S2808 |
Ipatasertib (GDC-0068)Ipatasertib (GDC-0068, RG7440)是一种高选择性的pan-Akt抑制剂,靶向作用于Akt1/2/3,在无细胞试验中IC50为5 nM/18 nM/8 nM,比作用于PKA选择性高620倍。Phase 2。 |
![]() ![]() Inhibition of AKT signaling abolishes MKK4 phosphorylation on Ser78 in injured axons. Cultures of sensory neurons were treated with 5 µM MK-2206 or 5 µM GDC-0068 for 1 hr prior to axotomy. Axonal proteins harvested at indicated time points after axotomy were subjected to immunoblot analysis.
|
|
S3355New |
3-Hydroxyanthranilic acid3-Hydroxyanthranilic Acid (3-HAA, 3-HANA)是一种色氨酸代谢物具有免疫调节作用,可能是通过抑制 PI3K/Akt/mTOR 和 NF-κB 活性,减少促炎性介质的产生。 |
||
S1273New |
AmarogentinAmarogentin (AG) 是一种主要从 Swertia 和 Gentiana 根中提取的裂环烯醚苷,具有抗氧化、抗肿瘤和抗糖尿病的作用。Amarogentin 是苦味受体 TAS2R1 的激动剂,可抑制LAD-2细胞中substance P诱导的新合成的 TNF-α 的产生。Amarogentin 通过 G2/M 细胞周期的阻滞和 PI3K/Akt 信号通路诱导人胃癌细胞(SNU-16)的凋亡。Amarogentin (AG) 可与 AMP-activated protein kinase (AMPK) 的α2亚基相互作用,并激活三聚体激酶,其EC50值为277 pM。 |
||
S1321New |
Urolithin BUrolithin B 通过减少 IκBα 的磷酸化和降解来抑制 NF-κB 活性。Urolithin B 可抑制 JNK、ERK 和 Akt 的磷酸化,并增强 AMPK 的磷酸化。Urolithin B 也是 skeletal muscle mass 的调节剂。 |
||
S3309New |
SolasodineSolasodine (Purapuridine, Solancarpidine, Solasodin, Salasodine, Salasdine) 是一种存在于茄科植物中的有毒的生物碱化合物。Solasodine 可降低 matrix metalloproteinase-2 (MMP-2)、MMP-9 和 matrix metalloproteinase (EMMPRIN) 的细胞外诱导剂的mRNA水平,但会增加 reversion-inducing cysteine-rich protein with kazal motifs (RECK)。Solasodine 下调致癌的 microRNA-21 (miR-21),已知其靶向RECK。Solasodine 还可以减少 PI3K/Akt 信号传导途径并下调miR-21的表达。 |
||
S3224New |
CinobufaginCinobufagin (Cinobufagine) 是 Venenum Bufonis 的活性成分,可抑制肿瘤发展。Cinobufagin 可提高 ATM 和 Chk2 并降低 CDC25C、CDK1 和 cyclin B。Cinobufagin 抑制 PI3K、AKT 和 Bcl-2,同时增加裂解的 caspase-9 和 caspase-3 水平。由此诱导细胞周期停滞在G2/M期及凋亡。 |
||
S3238New |
ResibufogeninResibufogenin (Bufogenin, Recibufogenin) 是huachansu华蟾素中具有抗癌作用的成分,通过上调 receptor-interacting protein kinase 3 (RIP3) 和磷酸化 mixed lineage kinase domain-like protein 的Ser358位点来触发坏死病。Resibufogenin 可通过诱导 reactive oxygen species (ROS) 积累发挥细胞毒性作用。Resibufogenin 可诱导凋亡和 caspase-3 和 caspase-8 活性。Resibufogenin 增加 Bax/Bcl-2 表达,并抑制 cyclin D1、cyclin E、PI3K、p-AKT、p-GSK3β 和 β-catenin 的蛋白表达。 |
||
S3296New |
HispidulinHispidulin (Dinatin) 是一种在许多传统中草药中存在的天然活性成分,对癌蛋白激酶 Pim-1 具有抑制活性,其IC50值为2.71 μM。Hispidulin 通过 mitochondrial dysfunction 来诱导凋亡,并可抑制HepG2癌细胞中的 P13k/Akt 的信号通路。Hispidulin 通过激活 AMPK 信号通路发挥抗骨质疏松和骨吸收减弱的作用。 |
||
S3220New |
TrigonellineTrigonelline (Trigenolline) 是一种植物生物碱,是咖啡和葫芦巴的主要成分,具有抗脱粒、抗糖尿病、抗氧化、抗炎和神经保护的作用。 Trigonelline 可抑制FcεRI介导的细胞内信号通路,例如 PLCγ1、PI3K 和 Akt 的磷酸化。Trigonelline (Trigenolline) 还可抑制RBL-2H3细胞中 microtubule 的形成。 |
||
S3241New |
Loureirin ALoureirin A 是一种黄酮类化合物,从被称为龙血的来源于Dracaena cochinchinensis的红色树脂中提取出来。Loureirin A 可通过破坏 PI3K/Akt 信号传导来抑制血小板platelet活化。Loureirin A 可抑制 Akt 磷酸化。 |
||
S6847New |
ML-9 HClML-9 HCl (ML-9 hydrochloride) 是一种有效的选择性的 Akt kinase、myosin light chain kinase (MLCK) 和 stromal interaction molecule 1 (STIM1)。ML-9 HCl 也是 Ca2+-permeable channels 的有效抑制剂。ML-9 HCl 是一种靶向自噬和细胞死亡的亲溶酶体剂。 |
||
S6811New |
Miransertib (ARQ-092)Miransertib(ARQ-092)是一种有效的、选择性的和口服可生物利用的 Akt 变构抑制剂,其对Akt1、Akt2和Akt3的IC50值分别为2.7 nM、14 nM和8.1 nM。 |
||
S9611New |
ABTL-0812ABTL0812 (α-Hydroxylinoleic acid, LP-10218, SCLN-0812) 可在肺鳞癌细胞系中通过诱导TRIB3的过表达和激活自噬来抑制 Akt/mTOR 轴。ABTL0812 还可诱导 AMPK 激活和 ROS 积累。 |
||
S8500New |
BAY1125976BAY 1125976是一种选择性的变构AKT1/2抑制剂,对小鼠模型中AKT信号依赖性的肿瘤生长具有较强功效。在10 µM ATP时BAY 1125976对 AKT1、AKT2和AKT3的ic50分别为 5.2 nM、18 nM和427 nM,在2 mM ATP时BAY 1125976对AKT1和AKT2的ic50分别为 44 nM和36 nM。 |
||
S8019 |
Capivasertib (AZD5363)Capivasertib (AZD5363)有效抑制Akt(Akt1/Akt2/3)的所有亚型,在无细胞试验中IC50为3 nM/8 nM/8 nM,对P70S6K/PKA也具有相似的抑制效果,而对ROCK1/2抑制活性较低。Phase 2。 |
![]() ![]() Inhibition of PI3K and Akt by LY294002 and AZD5363 was confirmed by analyzing expression and activation status of the ribosomal protein S6 by Western blot analysis of PC-3 clone #14 cells treated with 0.5 or 5 uM AZD5363 (AZD) and 10 uM LY294002 (LY). Tubulin was used as a loading control.
|
|
S2743 |
PF-04691502PF-04691502 (PF4691502) 是一种ATP竞争性的PI3K(α/β/δ/γ)/mTOR双重抑制剂,在无细胞试验中Ki为1.8 nM/2.1 nM/1.6 nM/1.9 nM和16 nM,对Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38 和 JNK 几乎没有作用活性。PF-04691502 可诱导凋亡。Phase 2。 |
![]() ![]() BMDMs from WT animals were treated with different concentrations of PI3K inhibitors (500 nmol/L PF4691502, PI-103, BKM120 and 25 μmol/L SF1126) followed by hypoxia for 4 hours for Western blots. These macrophages were either used for lysate preparation (nuclear extracts for HIFα or WCE for pAKT and AKT) and Western blot analysis.
|
|
S1558 |
AT7867AT7867是一种有效的,ATP竞争性的Akt1/2/3和p70S6K/PKA抑制剂,无细胞试验中IC50分别为32 nM/17 n/47 nM和85 nM/20 nM,对AGC激酶家族以外几乎没有抑制活性。 |
![]() ![]() UMUC-6 cells were treated with the indicated concentrations of AT7867 for 72 hours. Relative cytotoxicity compared to untreated control cells was assessed by alamarBlue. Each data points represents the mean of three independent experiments and the error bars represent the standard error of the mean. |
|
S1117 |
TriciribineTriciribine (NSC 154020, VD-0002, vqd-002, API-2) 是一种DNA synthesis抑制剂,也抑制PC3细胞系中的Akt和CEM-SS,H9,H9IIIB,U1细胞中的HIV-1,IC50分别为130 nM和20 nM;对PI3K/PDK1没有抑制作用;作用于缺乏腺苷激酶的细胞,活性降低5000倍。Phase 1/2。 |
![]() ![]() Effect of triciribine on the migration of (A) FaDu and (B) Hep2 cells. The cells were treated with 5 µM triciribine for different periods of time. *P<0.05 vs. control. Hpf, high-power field. |
|
S2635 |
CCT128930CCT128930 是一种有效的,ATP竞争性的,选择性Akt2抑制剂,无细胞试验中IC50为6 nM,作用于Akt2比作用于紧密相关的PKA激酶选择性高28倍。CCT128930 可不依赖与Akt抑制地诱导细胞周期阻滞、DNA损伤和自噬。高浓度的CCT128930在HepG2细胞可触发细胞凋亡。 |
![]() ![]() PI3K/AKT were involved in the E2 induced decrease of Caov-3 cell anoikis. Caov-3 cells were pretreated by different signaling pathway inhibitors and Bit1 expression was determined by western blotting.
|
|
S2670 |
A-674563A-674563是一种Akt抑制剂,在无细胞试验中Ki为11 nM,对PKA适度有效,作用于Akt1比作用于PKC选择性高30多倍。 |
![]() ![]() B cells were pre-treated with the indicated concentrations of A-674563 for 1h prior to R848 treatment (500 ng/ml). Thymidine incorporation was analyzed 24h later. |
|
S1556 |
PHT-427PHT-427 (CS-0223)是作用于Akt和PDPK1的双重抑制剂,对Akt和PDPK1的PH结构域具有高度亲和力,Ki分别为2.7 μM和5.2 μM。 |
![]() ![]() The inhibition of PI3K/Akt pathway is involved in ATG-induced FOXO3a dephosphorylation in PDGF-BB-activated HSCs. Serum-starved LX-2 human HSCs were pretreated with or without DMSO (vehicle) or ATG (0.5 uM) for 4 h, in the absence or presence of PI3K inhibitor LY294002 (20 uM) or Akt inhibitor PHT-427 (20 uM), and then incubated with or without 50 ng/ml PDGF-BB for 4 h. After treatment, aliquots of whole cell lysates were collected and subjected to Western blotting analysis. The experiments were repeated three times with similar results and a representative blot was shown for each protein. Total protein levels of Akt and FOXO3a served as internal controls.
|
|
S3056 |
MiltefosineMiltefosine (Hexadecylphosphocholine)作用于癌细胞系A431和HeLa,抑制PI3K/Akt活性,ED50分别为17.2 μM和8.1 μM,是第一个用于治疗内脏利什曼病的口服药物,有效对抗前鞭毛体和无鞭毛体。 |
![]() ![]() Effects of a miltefosine co-treatment with celecoxib on steatohepatitis, hepatocyte apoptosis, Akt activation and p53 expression in the liver of MCD-diet fed mice. Mice were fed the control diet, an MCD diet, an MCD diet with celecoxib (20 mg/kg/day) treatment, or an MCD diet co-treatment with celecoxib and miltefosine (50 mg/kg/day) for 3 weeks. (C) TUNEL-stained sections of liver samples are representative of the indicated groups (magnification×400). Abbreviations: MCD, methionine and choline deficient; CON, control; CEL, celecoxib; MTF, miltefosine. |
|
S2310 |
HonokiolHonokiol 是木兰的有效成分,抑制Akt磷酸化,且促进ERK1/2磷酸化。Honokiol 可造成 G0/G1 期阻滞,并可通过 ROS/ERK1/2 信号通路来诱导凋亡和自噬。Honokiol 可抑制 hepatitis C virus (HCV) 感染。Phase 3。 |
![]() ![]() (B) Cleaved PARP, Bax and Bcl2 protein expression was evaluated by immunoblotting of KRAS mutant cells lysates after 48 h of honokiol (10, 20, 40, and 60 μM) treatment. ∗∗P < 0.01 and ∗∗∗P < 0.001 for comparison between control group and honokiol-treated group. |
|
S7127 |
TIC10 AnalogueTIC10 Analogue是一种TIC10的类似物,其抑制Akt和ERK活性,通过FoxO3a诱导TRAIL,具有优越的耐药性,可以穿透血脑屏障,具有超强的稳定性,和改善的药代动力学。Phase 1/2。 |
||
S9190 |
Oroxin BOroxin B (Hypocretin-2), one of flavonoids isolated from traditional Chinese herbal medicine Oroxylum indicum (L.) Vent, selectively induces tumor-suppressive ER stress in malignant lymphoma cells and has antioxidant activity. Oroxin B significantly inhibits proliferation and induce apoptosis, which may be strongly associated with the inhibiting COX-2/VEGF and PTEN/PI3K/AKT signaling pathway in SMMC-7721 cells, Oroxin B potentially be used as a novel therapeutic agent for liver cancer.COX-2, VEGF, PI3K, and p-AKT expression levels are downregulated, while PTEN is upregulated after Oroxin B treatment. |
||
S8839 |
BorussertibBorussertib是AKT的共价变构抑制剂,对野生型AKT的IC50值为0.8 nM,Ki值为2.2 nM。 |
||
S5554 |
Lanatoside CLanatoside C 是具有抗病毒和抗肿瘤活性的强心苷。Lanatoside C 通过减弱 MAPK,Wnt,JAK-STAT和PI3K/AKT/mTOR信号通路,诱导G2/M细胞周期停滞并诱导自噬和细胞凋亡。 |
||
S3901 |
Astragaloside IVAstragaloside IV (AST-IV, AS-IV) is a bioactive saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine. It has various effect on the cardiovascular, immune, digestive, and nervous systems. AS-IV suppresses activation of p-Akt, p-mTOR, p-NF-κB and p-Erk1/2. |
||
S7492 |
Uprosertib (GSK2141795)Uprosertib (GSK2141795, GSK795)是一种选择性的,ATP竞争性的,具有口服活性的Akt抑制剂,其对Akt 1/2/3的 IC50分别为180 nM, 328 nM和38 nM。Phase 2。 |
![]() ![]() Parental cell line wastreated with Akt inhibitor (GSK2141795) and BGJ398. The 5 uM BGJ398 resistant cell line was treated with GSK2141795, BGJ398, and 2 concentrations of GSK2141795 and varying dosages of BGJ398. The parental cell line treated with GSK2141795, the dark green line, indicates minimal effect of the inhibitor compared to the resistant cell line treated GSK2141795, the light purple line.
However, when the resistant cell line is treated with both GSK2141795 and BGJ398 there is a greater decrease in cell viability compared to the resistant cell line that is treated only with GSK2141795.
|
|
S7963 |
TIC10 (ONC201)TIC10 (ONC201) 抑制Akt和ERK活性,通过FoxO3a诱导TNF-related apoptosis-inducing ligand (TRAIL),具有优越的耐药性,可以穿透血脑屏障,具有超强的稳定性,和改善的药代动力学性能。Phase 1/2。 |
![]() ![]() Established HCC cell lines, HepG2 (A-C) and Huh-7 (D), primary human HCC cells (D, "Pri_1/Pri _2"), as well as HL-7702 human hepatocytes (D) and primary human adult hepatocytes ("Hepatocytes", D), were either left untreated ("C", same for all figures), or treated with applied concentration of TIC10 (0.1-30 μM), cells were then cultured in conditional medium for applied time; Cell proliferation was tested by MTT assay (A and D), clonogenicity assay (B) and [H3] Thymidine incorporation assay (C). Experiments in this figure were repeated for five times, with similar results obtained. n = 5 for each repeat. Bars stand for mean ± SD. *p < 0.05 vs. group "C".
|
|
S7776 |
Akti-1/2Akti-1/2 (Akt Inhibitor VIII)是高度选择性的Akt1/Akt2抑制剂,IC50分别为58 nM/210 nM,对Akt1的选择性比对Akt3高36倍。Akti-1/2 可诱导凋亡。 |
![]() ![]() AKTi-1/2 inhibits human HCC cells in vitro. Human HCC HepG2 cells (A–F), Huh-7 cells (G), primary human HCC cells (“Pri HCC”, G) or the primary liver cells (“Pri liver cells”, G) were treated with/out applied concentrations of AKTi-1/2 for indicated time; Cell survival (A, B and G), proliferation (C and D) and apoptosis (E and F) were tested by the listed assays. Data were shown as the mean (n = 5) with the standard deviation (SD). Experiments in this figure were repeated three times, with similar results were obtained. *P < 0.05 vs. “C” (untreated control) group.
|
|
S5313 |
SC66SC66 is an allosteric inhibitor which displays a dual-inhibitory function toward AKT activity with IC50 values of 0.77, 2.85 and 0.47 μg/ml in HepG2, Huh7 and Hep3B cells after 72 h treatment, respectively. |
||
S4953 |
Usnic acidUsnic acid (Usniacin)是存在于lichen(地衣)中的一种呋喃二酮,广泛应用于化妆品、除臭剂、牙膏和药用霜、中草药成品中。它具有抗病毒、抗原生动物、抗增殖和抗炎、止痛活性。Usnic acid 可通过抑制VEGFR2介导的 AKT 和 ERK1/2 信号通路来抑制乳腺肿瘤血管生成和生长。 |
||
S8339 |
Miransertib (ARQ 092) HClMiransertib (ARQ 092) HCl是新型的、具有口服生物活性的、选择性的AKT抑制剂,在晚期实体肿瘤中具有较好的、可调控的安全性。 |
![]() ![]() ARQ-092, a novel pan-AKT inhibitor, promotes axonal recovery when applied pre- and post-OGD. ARQ-092, which is an inhibitor of activated AKT, promoted axon function recovery when applied as a pre-treatment and as a post-treatment. A) Pre-treatment with ARQ-092 (500 nM, dark blue) applied before OGD promoted consistent and sustained CAP area recovery. B) ARQ-092 improved CAP area recovery at 250 nM and 500 nM when compared to control CAP area recovery. C) ARQ-092 (500 nM, brown) applied after OGD promoted consistent and sustained CAP area recovery. D) ARQ-092 improved CAP area recovery at 250 and 500 nM compared to control CAP area recovery. *p < 0.05 and **p < 0.01, one-way ANOVA with Newman-Keuls post hoc test. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
|
|
S3785 |
Notoginsenoside R1Notoginsenoside R1 (Sanchinoside R1) is the main ingredient with cardiovascular activity in Panax notoginseng. It inhibits TNF-α-induced PAI-1 overexpression via extracellular signal-related kinases (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling pathways. |
||
S7521 |
Afuresertib (GSK2110183)Afuresertib (GSK2110183)是一种有效的,口服生物可利用的 Akt 抑制剂,对Akt1,Akt2,和 Akt3 的 Ki 分别为 0.08 nM,2 nM,和 2.6 nM。Phase 2。 |
![]() ![]() Analysis of the mechanism of action of the enhanced anti‑tumor effect of the combination therapy of suboptimal doses of pomalidomide plus dexamethasone and afuresertib in MM cells. (A‑C) The altered expression of protein substrates was analyzed in two MM cell lines that were treated with suboptimal doses of PD, or AFU, or the PD and AFU combination. The XG‑7 and U266 cell lines were subjected to the indicated treatments for 48 and 72 h, respectively. (A) Caspases, (B) substrates related mainly to the working mechanism of IMiDs, (C) substrates mainly related to the working mechanism of afuresertib, and (D) two primary MM cell cultures, were subjected to the analysis in the same manner as the two MM cell lines. In the expression panel of p‑FoxO3a/FoxO1, the upper band represents p‑FoxO3a and the lower band represents p‑FOXO1. PD, pomalidomide plus dexamethasone; AFU, Afuresertib; MM, multiple myeloma; IMiDs, immunomodulatory drugs.
|
|
S9315 |
Praeruptorin APraeruptorin A, a naturally existing pyranocumarin, is isolated from the dried root of Peucedanum praeruptorum Dunn. Praeruptorin A inhibits p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation. Praeruptorin A can significantly upregulates multidrug resistance-associated protein 2 expression via the constitutive androstane receptor-mediated pathway in vitro, and this should be taken as an herb-drug interaction. |
||
S2335 |
OridoninOridonin (Isodonol, Rubescenin, NSC-250682) 是从Rabdosia rubescens中分离的对映贝壳杉烷二萜,是一种具有抗肿瘤、抗细菌和抗感染效果的传统中药。Oridonin 抑制AKT1 和 AKT2的激酶活性,对应的IC50值分别为8.4 μM 和 8.9 μM。 |
![]() ![]() Histopathological analysis of H460 tumors following combination treatment with oridonin and radiation. Hematoxylin and eosin (H-E) staining and immunohistochemistry for cleaved caspase-3 and γ-H2AX were performed on tumors harvested at 14 days after IR. Representative images of H-E-stained tumors (upper images) and cleaved caspase-3- and γ-H2AX-positive cells (middle images, brown staining) and quantification of cleaved caspase-3 and γ-H2AX-positive staining with six mice in each group (lower plots, means ± SEM) are shown; * p < 0.05.
|
|
S3810 |
ScutellarinScutellarin (Breviscapine, Breviscapin, Scutellarein-7-glucuronide)是从中草药黄芩Scutellaria baicalensis和灯盏细辛Erigeron breviscapus中提取的主要活性类黄酮,具有许多药理作用,例如抗氧化、抗肿瘤、抗病毒和抗炎活性。Scutellarin 可以下调HCC细胞中的 STAT3/Girdin/Akt 信号传导,并抑制破骨细胞中RANKL介导的 MAPK 和 NF-κB 信号通路。 |
||
S7563 |
AT13148AT13148是一种口服的,ATP竞争性的,多AGC kinase抑制剂,对Akt1/2/3,p70S6K,PKA,和ROCKI/II的IC50分别为38 nM/402 nM/50 nM,8 nM,3 nM,和6 nM/4 nM。Phase 1。 |
![]() ![]() AT13148 exerts cytotoxic and anti-proliferative activity against human gastric cancer cells. Human gastric cancer cells (HGC-27, AGS, SNU-601, N87 and MKN-28 lines) or GEC-1 gastric epithelial cells were treated with applied concentration of AT13148 for indicated time, cell survival (A and E), cell proliferation (B and F), cell cycle distribution (C, for HGC-27 cells) and cell death (D, for HGC-27 cells) were tested by the described assays, separately. Data were presented as mean ± SD. “Ctrl” stands for untreated control cells (For all figures). “hr/hrs” stands for hour/hours (For all figures). Experiments in this figure were repeated for five times. *p < 0.05 vs. “Ctrl” group.
|
|
S8132 |
DeguelinDeguelin,一种从植物中分离出来的天然产物,是PI3K/Akt的抑制剂。 |
||
S3294New |
Demethyl-CoclaurineDemethyl-Coclaurine (Higenamine, Norcoclaurine) 是中草药乌头根的关键成分,是一种 beta-2 adrenergic receptor (β2-AR) 的激动剂。Demethyl-Coclaurine 可刺激 AKT 的磷酸化,需要 PI3K 的激活才能使心肌细胞产生抗凋亡的作用。 |
||
S0765New |
MAZ51MAZ51 是一种选择性的 vascular endothelial growth factor receptor (VEGFR)-3 (Flt-4) tyrosine kinase 的有效抑制剂。MAZ51 通过 Akt/GSK3β 的磷酸化和 RhoA 的激活来诱导神经胶质瘤细胞的细胞圆缩和G2/M细胞周期停滞。 MAZ51 可抑制多种非VEGFR-3表达肿瘤细胞的增殖并诱导其凋亡。 |
||
S6760New |
LM22B-10LM22B-10 是一种小分子 TrkB/TrkC 神经营养蛋白受体共激活因子,LM22B-10 在体内和体外均可选择性地激活 TrkB、TrkC、AKT 和 ERK。 |
||
S5144 |
NeferineNeferine ((R)-1,2-Dimethoxyaporphine) 是 Nelumbo nucifera 的天然成分,具有抗肿瘤功效。Neferine 可诱导肾癌细胞凋亡。Neferine 通过激活肌肉细胞中的 Akt/mTOR 通路和 Nrf2 来防止自噬。Neferine 可抑制 NF-κB 的激活。Neferine具有多种治疗作用,例如抗糖尿病,抗衰老,抗微生物,抗血栓形成,抗心律不齐,抗炎甚至抗HIV。 |
||
S7863 |
SC79SC79是一种大脑渗透性Akt磷酸化激活剂,也是一种Akt-PH域易位抑制剂。 |
![]() ![]() Cells with OGN over-expression were challenged with EGF (100 ng/mL) and pretreated with SC79 (constitutive Akt activator) for 24 h. Western blotting with the significantly altered markers was performed.
|
|
S3289New |
DaphnoretinDaphnoretin (Dephnoretin, Thymelol) 是一种从Wikstroemia indica C.A. Mey.中提取的具有生物活性的化合物,是 protein kinase C (PKC) 的激活剂。Daphnoretin 通过调节 Akt 信号通路的活性,来抑制肿瘤细胞的增殖、侵袭和迁移,促进其凋亡。 |
||
S6885New |
AilanthoneAilanthone (AIL, Δ13-Dehydrochaparrinone) 是一种来自臭椿Ailanthus altissima的天然通过抗肝癌(HCC)成分,可通过降低 cyclins 和 CDKs 的表达、提高 p21 和 p27 的表达来诱导G0/G1期细胞周期阻滞。Ailanthone 可触发DNA损伤,其特征为 ATM/ATR 通路的激活。Ailanthone 可在Huh7细胞中诱导线粒体介导、涉及 PI3K/AKT 信号通路的细胞凋亡。Ailanthone 也是全长 Androgen Receptor (AR-FL)和组成型活性截断AR剪接变体(AR-Vs, AR1-651)的抑制剂,对应的IC50值分别为69 nM和309 nM。 |
||
S8961New |
Alobresib (GS-5829)Alobresib (GS-5829) 是一种新型的 BET 抑制剂,是一种针对复发/耐药的USC过表达c-Myc的高效治疗剂。Alobresib (GS-5829) 可抑制CLL细胞增殖并通过解除如 BLK、AKT、ERK1/2和MYC等关键信号通路的管制来诱导白血病细胞凋亡apoptosis。Alobresib (GS-5829) 还可抑制 NF-κB 的信号传导。 |
||
S9514 |
Rotundic acidRotundic acid (Rutundic acid)是一种天然化合物,对人肝细胞癌(HepG2)、恶性黑色素瘤(A375)、SCLC(NCI-H446)、乳腺癌(MCF-7)和结肠癌(HT-29)细胞系表现出细胞毒活性。Rotundic acid 通过调节 AKT/mTOR and MAPK pathways 诱导细胞周期停滞、DNA损伤和细胞凋亡。 |
||
S2323 |
Methyl-HesperidinMethyl-Hesperidin 是一种在柑橘类水果中广泛存在的黄酮苷(黄酮)(C28H34O15),其苷元形式被称为橙皮素。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S1078 |
MK-2206 2HClMK-2206 2HCl是一种高度选择性的Akt1/2/3抑制剂,在无细胞试验中IC50分别为8 nM/12 nM/65 nM;对250种其他蛋白激酶没有抑制活性。MK-2206 2HCl 在肿瘤细胞中可诱导自噬和凋亡。Phase 2。 |
![]() ![]() VE-cadherin-induced Akt activation mediates YAP phosphorylation and translocation in ECs. HUVECs were starved for 1h and treated with thrombin (1U) for 1h. Total cell lysates were probed with anti-pAkt, Akt or b-actin antibody. The representative blots of three independent experiments are depicted, and the normalized values for p-Akt are shown. HUVECs were cultured and starved as described as in d and incubated for 8h in complete medium with the Akt inhibitor, MK-2206 (1 uM). pAkt, Akt, pYAP and YAP were detected by western blotting using specific antibodies.
|
|
S1037 |
Perifosine (KRX-0401)Perifosine (KRX-0401, NSC639966)是一种新型的Akt抑制剂,在MM.1S细胞中IC50为4.7 μM,靶向作用于Akt的pleckstrin同源结构域。Phase 3。 |
![]() ![]() Tumor growth of 827 GSC-derived xenografts
treated with an AKT inhibitor perifosine (30 mg/kg
body weight). Twenty-three days after tumor
implantation in mice, perifosine was administered
by intraperitoneal injection (daily for 5 days). Error
bars represent SD. Five mice per group, *p < 0.01.
|
|
S1113 |
GSK690693GSK690693 是一种泛Akt抑制剂,靶向作用于Akt1/2/3,在无细胞试验中IC50为2 nM/13 nM/9 nM,也对AGC激酶家族:PKA,PrkX和PKC同工酶敏感。GSK690693 也能有效地抑制CAMK家族的 AMPK 和 DAPK3,对应的IC50值分别为50 nM和81 nM。GSK690693 可影响 Unc-51-like autophagy activating kinase 1 (ULK1) 的活性并有效地抑制 STING-dependent IRF3 的激活。Phase 1。 |
![]() ![]() UPN cells were treated with GSK690693 or MK2206 (1 uM) for 1h followed by LPA (10 uM), EGF or IGF-1 (10 ng/ml) for another 1h and Western blot was performed. Band intensities of phospho-AKT (p-AKTS473), phospho-S6 (p-S6S240/S244), phospho-YB-1 (p-YB-1S102) and YB-1 were quantified and normalized to the intensity of ERK2. It directly determined the role of AKT using two potent, AKT inhibitors with distinct actions—a catalytic domain inhibitor, GSK690693, and an allosteric inhibitor, MK2206 -in UPN and SKOV3 cells, which showed appreciable AKT and YB-1 phosphorylation upon growth factor stimulation. GSK690693 increased basal and growth factor-induced AKT phosphorylation due to blocking a negative feedback loop downstream of AKT, whereas MK2206 abolished both basal and growth-factor-induced AKT phosphorylation.
|
|
S1362 |
Rigosertib (ON-01910)Rigosertib (ON-01910) 是一种非ATP竞争性PLK1抑制剂,无细胞试验中IC50为9 nM,比作用于Plk2选择性高30倍,对Plk3没有抑制活性。Rigosertib 可抑制 PI3K/Akt 信号通路并激活氧化应激信号。Rigosertib 可诱导多种癌细胞的凋亡。Phase 3。 |
![]() ![]() Along with cell death, immunoblotting shows ON 01910.Na induces hyperphosphorylation of RanGAP1, increased expression of RanGAP1.SUMO1 but decreased expression of free unmodified RanGAP1. No viable SU-DHL-5 cells were available for immunoblotting at 0.5 uM of ON 01910.Na.
|
|
S2808 |
Ipatasertib (GDC-0068)Ipatasertib (GDC-0068, RG7440)是一种高选择性的pan-Akt抑制剂,靶向作用于Akt1/2/3,在无细胞试验中IC50为5 nM/18 nM/8 nM,比作用于PKA选择性高620倍。Phase 2。 |
![]() ![]() Inhibition of AKT signaling abolishes MKK4 phosphorylation on Ser78 in injured axons. Cultures of sensory neurons were treated with 5 µM MK-2206 or 5 µM GDC-0068 for 1 hr prior to axotomy. Axonal proteins harvested at indicated time points after axotomy were subjected to immunoblot analysis.
|
|
S3355New |
3-Hydroxyanthranilic acid3-Hydroxyanthranilic Acid (3-HAA, 3-HANA)是一种色氨酸代谢物具有免疫调节作用,可能是通过抑制 PI3K/Akt/mTOR 和 NF-κB 活性,减少促炎性介质的产生。 |
||
S1273New |
AmarogentinAmarogentin (AG) 是一种主要从 Swertia 和 Gentiana 根中提取的裂环烯醚苷,具有抗氧化、抗肿瘤和抗糖尿病的作用。Amarogentin 是苦味受体 TAS2R1 的激动剂,可抑制LAD-2细胞中substance P诱导的新合成的 TNF-α 的产生。Amarogentin 通过 G2/M 细胞周期的阻滞和 PI3K/Akt 信号通路诱导人胃癌细胞(SNU-16)的凋亡。Amarogentin (AG) 可与 AMP-activated protein kinase (AMPK) 的α2亚基相互作用,并激活三聚体激酶,其EC50值为277 pM。 |
||
S1321New |
Urolithin BUrolithin B 通过减少 IκBα 的磷酸化和降解来抑制 NF-κB 活性。Urolithin B 可抑制 JNK、ERK 和 Akt 的磷酸化,并增强 AMPK 的磷酸化。Urolithin B 也是 skeletal muscle mass 的调节剂。 |
||
S3309New |
SolasodineSolasodine (Purapuridine, Solancarpidine, Solasodin, Salasodine, Salasdine) 是一种存在于茄科植物中的有毒的生物碱化合物。Solasodine 可降低 matrix metalloproteinase-2 (MMP-2)、MMP-9 和 matrix metalloproteinase (EMMPRIN) 的细胞外诱导剂的mRNA水平,但会增加 reversion-inducing cysteine-rich protein with kazal motifs (RECK)。Solasodine 下调致癌的 microRNA-21 (miR-21),已知其靶向RECK。Solasodine 还可以减少 PI3K/Akt 信号传导途径并下调miR-21的表达。 |
||
S3224New |
CinobufaginCinobufagin (Cinobufagine) 是 Venenum Bufonis 的活性成分,可抑制肿瘤发展。Cinobufagin 可提高 ATM 和 Chk2 并降低 CDC25C、CDK1 和 cyclin B。Cinobufagin 抑制 PI3K、AKT 和 Bcl-2,同时增加裂解的 caspase-9 和 caspase-3 水平。由此诱导细胞周期停滞在G2/M期及凋亡。 |
||
S3238New |
ResibufogeninResibufogenin (Bufogenin, Recibufogenin) 是huachansu华蟾素中具有抗癌作用的成分,通过上调 receptor-interacting protein kinase 3 (RIP3) 和磷酸化 mixed lineage kinase domain-like protein 的Ser358位点来触发坏死病。Resibufogenin 可通过诱导 reactive oxygen species (ROS) 积累发挥细胞毒性作用。Resibufogenin 可诱导凋亡和 caspase-3 和 caspase-8 活性。Resibufogenin 增加 Bax/Bcl-2 表达,并抑制 cyclin D1、cyclin E、PI3K、p-AKT、p-GSK3β 和 β-catenin 的蛋白表达。 |
||
S3296New |
HispidulinHispidulin (Dinatin) 是一种在许多传统中草药中存在的天然活性成分,对癌蛋白激酶 Pim-1 具有抑制活性,其IC50值为2.71 μM。Hispidulin 通过 mitochondrial dysfunction 来诱导凋亡,并可抑制HepG2癌细胞中的 P13k/Akt 的信号通路。Hispidulin 通过激活 AMPK 信号通路发挥抗骨质疏松和骨吸收减弱的作用。 |
||
S3220New |
TrigonellineTrigonelline (Trigenolline) 是一种植物生物碱,是咖啡和葫芦巴的主要成分,具有抗脱粒、抗糖尿病、抗氧化、抗炎和神经保护的作用。 Trigonelline 可抑制FcεRI介导的细胞内信号通路,例如 PLCγ1、PI3K 和 Akt 的磷酸化。Trigonelline (Trigenolline) 还可抑制RBL-2H3细胞中 microtubule 的形成。 |
||
S3241New |
Loureirin ALoureirin A 是一种黄酮类化合物,从被称为龙血的来源于Dracaena cochinchinensis的红色树脂中提取出来。Loureirin A 可通过破坏 PI3K/Akt 信号传导来抑制血小板platelet活化。Loureirin A 可抑制 Akt 磷酸化。 |
||
S6847New |
ML-9 HClML-9 HCl (ML-9 hydrochloride) 是一种有效的选择性的 Akt kinase、myosin light chain kinase (MLCK) 和 stromal interaction molecule 1 (STIM1)。ML-9 HCl 也是 Ca2+-permeable channels 的有效抑制剂。ML-9 HCl 是一种靶向自噬和细胞死亡的亲溶酶体剂。 |
||
S6811New |
Miransertib (ARQ-092)Miransertib(ARQ-092)是一种有效的、选择性的和口服可生物利用的 Akt 变构抑制剂,其对Akt1、Akt2和Akt3的IC50值分别为2.7 nM、14 nM和8.1 nM。 |
||
S9611New |
ABTL-0812ABTL0812 (α-Hydroxylinoleic acid, LP-10218, SCLN-0812) 可在肺鳞癌细胞系中通过诱导TRIB3的过表达和激活自噬来抑制 Akt/mTOR 轴。ABTL0812 还可诱导 AMPK 激活和 ROS 积累。 |
||
S8500New |
BAY1125976BAY 1125976是一种选择性的变构AKT1/2抑制剂,对小鼠模型中AKT信号依赖性的肿瘤生长具有较强功效。在10 µM ATP时BAY 1125976对 AKT1、AKT2和AKT3的ic50分别为 5.2 nM、18 nM和427 nM,在2 mM ATP时BAY 1125976对AKT1和AKT2的ic50分别为 44 nM和36 nM。 |
||
S8019 |
Capivasertib (AZD5363)Capivasertib (AZD5363)有效抑制Akt(Akt1/Akt2/3)的所有亚型,在无细胞试验中IC50为3 nM/8 nM/8 nM,对P70S6K/PKA也具有相似的抑制效果,而对ROCK1/2抑制活性较低。Phase 2。 |
![]() ![]() Inhibition of PI3K and Akt by LY294002 and AZD5363 was confirmed by analyzing expression and activation status of the ribosomal protein S6 by Western blot analysis of PC-3 clone #14 cells treated with 0.5 or 5 uM AZD5363 (AZD) and 10 uM LY294002 (LY). Tubulin was used as a loading control.
|
|
S2743 |
PF-04691502PF-04691502 (PF4691502) 是一种ATP竞争性的PI3K(α/β/δ/γ)/mTOR双重抑制剂,在无细胞试验中Ki为1.8 nM/2.1 nM/1.6 nM/1.9 nM和16 nM,对Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38 和 JNK 几乎没有作用活性。PF-04691502 可诱导凋亡。Phase 2。 |
![]() ![]() BMDMs from WT animals were treated with different concentrations of PI3K inhibitors (500 nmol/L PF4691502, PI-103, BKM120 and 25 μmol/L SF1126) followed by hypoxia for 4 hours for Western blots. These macrophages were either used for lysate preparation (nuclear extracts for HIFα or WCE for pAKT and AKT) and Western blot analysis.
|
|
S1558 |
AT7867AT7867是一种有效的,ATP竞争性的Akt1/2/3和p70S6K/PKA抑制剂,无细胞试验中IC50分别为32 nM/17 n/47 nM和85 nM/20 nM,对AGC激酶家族以外几乎没有抑制活性。 |
![]() ![]() UMUC-6 cells were treated with the indicated concentrations of AT7867 for 72 hours. Relative cytotoxicity compared to untreated control cells was assessed by alamarBlue. Each data points represents the mean of three independent experiments and the error bars represent the standard error of the mean. |
|
S1117 |
TriciribineTriciribine (NSC 154020, VD-0002, vqd-002, API-2) 是一种DNA synthesis抑制剂,也抑制PC3细胞系中的Akt和CEM-SS,H9,H9IIIB,U1细胞中的HIV-1,IC50分别为130 nM和20 nM;对PI3K/PDK1没有抑制作用;作用于缺乏腺苷激酶的细胞,活性降低5000倍。Phase 1/2。 |
![]() ![]() Effect of triciribine on the migration of (A) FaDu and (B) Hep2 cells. The cells were treated with 5 µM triciribine for different periods of time. *P<0.05 vs. control. Hpf, high-power field. |
|
S2635 |
CCT128930CCT128930 是一种有效的,ATP竞争性的,选择性Akt2抑制剂,无细胞试验中IC50为6 nM,作用于Akt2比作用于紧密相关的PKA激酶选择性高28倍。CCT128930 可不依赖与Akt抑制地诱导细胞周期阻滞、DNA损伤和自噬。高浓度的CCT128930在HepG2细胞可触发细胞凋亡。 |
![]() ![]() PI3K/AKT were involved in the E2 induced decrease of Caov-3 cell anoikis. Caov-3 cells were pretreated by different signaling pathway inhibitors and Bit1 expression was determined by western blotting.
|
|
S2670 |
A-674563A-674563是一种Akt抑制剂,在无细胞试验中Ki为11 nM,对PKA适度有效,作用于Akt1比作用于PKC选择性高30多倍。 |
![]() ![]() B cells were pre-treated with the indicated concentrations of A-674563 for 1h prior to R848 treatment (500 ng/ml). Thymidine incorporation was analyzed 24h later. |
|
S1556 |
PHT-427PHT-427 (CS-0223)是作用于Akt和PDPK1的双重抑制剂,对Akt和PDPK1的PH结构域具有高度亲和力,Ki分别为2.7 μM和5.2 μM。 |
![]() ![]() The inhibition of PI3K/Akt pathway is involved in ATG-induced FOXO3a dephosphorylation in PDGF-BB-activated HSCs. Serum-starved LX-2 human HSCs were pretreated with or without DMSO (vehicle) or ATG (0.5 uM) for 4 h, in the absence or presence of PI3K inhibitor LY294002 (20 uM) or Akt inhibitor PHT-427 (20 uM), and then incubated with or without 50 ng/ml PDGF-BB for 4 h. After treatment, aliquots of whole cell lysates were collected and subjected to Western blotting analysis. The experiments were repeated three times with similar results and a representative blot was shown for each protein. Total protein levels of Akt and FOXO3a served as internal controls.
|
|
S3056 |
MiltefosineMiltefosine (Hexadecylphosphocholine)作用于癌细胞系A431和HeLa,抑制PI3K/Akt活性,ED50分别为17.2 μM和8.1 μM,是第一个用于治疗内脏利什曼病的口服药物,有效对抗前鞭毛体和无鞭毛体。 |
![]() ![]() Effects of a miltefosine co-treatment with celecoxib on steatohepatitis, hepatocyte apoptosis, Akt activation and p53 expression in the liver of MCD-diet fed mice. Mice were fed the control diet, an MCD diet, an MCD diet with celecoxib (20 mg/kg/day) treatment, or an MCD diet co-treatment with celecoxib and miltefosine (50 mg/kg/day) for 3 weeks. (C) TUNEL-stained sections of liver samples are representative of the indicated groups (magnification×400). Abbreviations: MCD, methionine and choline deficient; CON, control; CEL, celecoxib; MTF, miltefosine. |
|
S2310 |
HonokiolHonokiol 是木兰的有效成分,抑制Akt磷酸化,且促进ERK1/2磷酸化。Honokiol 可造成 G0/G1 期阻滞,并可通过 ROS/ERK1/2 信号通路来诱导凋亡和自噬。Honokiol 可抑制 hepatitis C virus (HCV) 感染。Phase 3。 |
![]() ![]() (B) Cleaved PARP, Bax and Bcl2 protein expression was evaluated by immunoblotting of KRAS mutant cells lysates after 48 h of honokiol (10, 20, 40, and 60 μM) treatment. ∗∗P < 0.01 and ∗∗∗P < 0.001 for comparison between control group and honokiol-treated group. |
|
S7127 |
TIC10 AnalogueTIC10 Analogue是一种TIC10的类似物,其抑制Akt和ERK活性,通过FoxO3a诱导TRAIL,具有优越的耐药性,可以穿透血脑屏障,具有超强的稳定性,和改善的药代动力学。Phase 1/2。 |
||
S9190 |
Oroxin BOroxin B (Hypocretin-2), one of flavonoids isolated from traditional Chinese herbal medicine Oroxylum indicum (L.) Vent, selectively induces tumor-suppressive ER stress in malignant lymphoma cells and has antioxidant activity. Oroxin B significantly inhibits proliferation and induce apoptosis, which may be strongly associated with the inhibiting COX-2/VEGF and PTEN/PI3K/AKT signaling pathway in SMMC-7721 cells, Oroxin B potentially be used as a novel therapeutic agent for liver cancer.COX-2, VEGF, PI3K, and p-AKT expression levels are downregulated, while PTEN is upregulated after Oroxin B treatment. |
||
S8839 |
BorussertibBorussertib是AKT的共价变构抑制剂,对野生型AKT的IC50值为0.8 nM,Ki值为2.2 nM。 |
||
S5554 |
Lanatoside CLanatoside C 是具有抗病毒和抗肿瘤活性的强心苷。Lanatoside C 通过减弱 MAPK,Wnt,JAK-STAT和PI3K/AKT/mTOR信号通路,诱导G2/M细胞周期停滞并诱导自噬和细胞凋亡。 |
||
S3901 |
Astragaloside IVAstragaloside IV (AST-IV, AS-IV) is a bioactive saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine. It has various effect on the cardiovascular, immune, digestive, and nervous systems. AS-IV suppresses activation of p-Akt, p-mTOR, p-NF-κB and p-Erk1/2. |
||
S7492 |
Uprosertib (GSK2141795)Uprosertib (GSK2141795, GSK795)是一种选择性的,ATP竞争性的,具有口服活性的Akt抑制剂,其对Akt 1/2/3的 IC50分别为180 nM, 328 nM和38 nM。Phase 2。 |
![]() ![]() Parental cell line wastreated with Akt inhibitor (GSK2141795) and BGJ398. The 5 uM BGJ398 resistant cell line was treated with GSK2141795, BGJ398, and 2 concentrations of GSK2141795 and varying dosages of BGJ398. The parental cell line treated with GSK2141795, the dark green line, indicates minimal effect of the inhibitor compared to the resistant cell line treated GSK2141795, the light purple line.
However, when the resistant cell line is treated with both GSK2141795 and BGJ398 there is a greater decrease in cell viability compared to the resistant cell line that is treated only with GSK2141795.
|
|
S7963 |
TIC10 (ONC201)TIC10 (ONC201) 抑制Akt和ERK活性,通过FoxO3a诱导TNF-related apoptosis-inducing ligand (TRAIL),具有优越的耐药性,可以穿透血脑屏障,具有超强的稳定性,和改善的药代动力学性能。Phase 1/2。 |
![]() ![]() Established HCC cell lines, HepG2 (A-C) and Huh-7 (D), primary human HCC cells (D, "Pri_1/Pri _2"), as well as HL-7702 human hepatocytes (D) and primary human adult hepatocytes ("Hepatocytes", D), were either left untreated ("C", same for all figures), or treated with applied concentration of TIC10 (0.1-30 μM), cells were then cultured in conditional medium for applied time; Cell proliferation was tested by MTT assay (A and D), clonogenicity assay (B) and [H3] Thymidine incorporation assay (C). Experiments in this figure were repeated for five times, with similar results obtained. n = 5 for each repeat. Bars stand for mean ± SD. *p < 0.05 vs. group "C".
|
|
S7776 |
Akti-1/2Akti-1/2 (Akt Inhibitor VIII)是高度选择性的Akt1/Akt2抑制剂,IC50分别为58 nM/210 nM,对Akt1的选择性比对Akt3高36倍。Akti-1/2 可诱导凋亡。 |
![]() ![]() AKTi-1/2 inhibits human HCC cells in vitro. Human HCC HepG2 cells (A–F), Huh-7 cells (G), primary human HCC cells (“Pri HCC”, G) or the primary liver cells (“Pri liver cells”, G) were treated with/out applied concentrations of AKTi-1/2 for indicated time; Cell survival (A, B and G), proliferation (C and D) and apoptosis (E and F) were tested by the listed assays. Data were shown as the mean (n = 5) with the standard deviation (SD). Experiments in this figure were repeated three times, with similar results were obtained. *P < 0.05 vs. “C” (untreated control) group.
|
|
S5313 |
SC66SC66 is an allosteric inhibitor which displays a dual-inhibitory function toward AKT activity with IC50 values of 0.77, 2.85 and 0.47 μg/ml in HepG2, Huh7 and Hep3B cells after 72 h treatment, respectively. |
||
S4953 |
Usnic acidUsnic acid (Usniacin)是存在于lichen(地衣)中的一种呋喃二酮,广泛应用于化妆品、除臭剂、牙膏和药用霜、中草药成品中。它具有抗病毒、抗原生动物、抗增殖和抗炎、止痛活性。Usnic acid 可通过抑制VEGFR2介导的 AKT 和 ERK1/2 信号通路来抑制乳腺肿瘤血管生成和生长。 |
||
S8339 |
Miransertib (ARQ 092) HClMiransertib (ARQ 092) HCl是新型的、具有口服生物活性的、选择性的AKT抑制剂,在晚期实体肿瘤中具有较好的、可调控的安全性。 |
![]() ![]() ARQ-092, a novel pan-AKT inhibitor, promotes axonal recovery when applied pre- and post-OGD. ARQ-092, which is an inhibitor of activated AKT, promoted axon function recovery when applied as a pre-treatment and as a post-treatment. A) Pre-treatment with ARQ-092 (500 nM, dark blue) applied before OGD promoted consistent and sustained CAP area recovery. B) ARQ-092 improved CAP area recovery at 250 nM and 500 nM when compared to control CAP area recovery. C) ARQ-092 (500 nM, brown) applied after OGD promoted consistent and sustained CAP area recovery. D) ARQ-092 improved CAP area recovery at 250 and 500 nM compared to control CAP area recovery. *p < 0.05 and **p < 0.01, one-way ANOVA with Newman-Keuls post hoc test. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
|
|
S3785 |
Notoginsenoside R1Notoginsenoside R1 (Sanchinoside R1) is the main ingredient with cardiovascular activity in Panax notoginseng. It inhibits TNF-α-induced PAI-1 overexpression via extracellular signal-related kinases (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling pathways. |
||
S7521 |
Afuresertib (GSK2110183)Afuresertib (GSK2110183)是一种有效的,口服生物可利用的 Akt 抑制剂,对Akt1,Akt2,和 Akt3 的 Ki 分别为 0.08 nM,2 nM,和 2.6 nM。Phase 2。 |
![]() ![]() Analysis of the mechanism of action of the enhanced anti‑tumor effect of the combination therapy of suboptimal doses of pomalidomide plus dexamethasone and afuresertib in MM cells. (A‑C) The altered expression of protein substrates was analyzed in two MM cell lines that were treated with suboptimal doses of PD, or AFU, or the PD and AFU combination. The XG‑7 and U266 cell lines were subjected to the indicated treatments for 48 and 72 h, respectively. (A) Caspases, (B) substrates related mainly to the working mechanism of IMiDs, (C) substrates mainly related to the working mechanism of afuresertib, and (D) two primary MM cell cultures, were subjected to the analysis in the same manner as the two MM cell lines. In the expression panel of p‑FoxO3a/FoxO1, the upper band represents p‑FoxO3a and the lower band represents p‑FOXO1. PD, pomalidomide plus dexamethasone; AFU, Afuresertib; MM, multiple myeloma; IMiDs, immunomodulatory drugs.
|
|
S9315 |
Praeruptorin APraeruptorin A, a naturally existing pyranocumarin, is isolated from the dried root of Peucedanum praeruptorum Dunn. Praeruptorin A inhibits p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation. Praeruptorin A can significantly upregulates multidrug resistance-associated protein 2 expression via the constitutive androstane receptor-mediated pathway in vitro, and this should be taken as an herb-drug interaction. |
||
S2335 |
OridoninOridonin (Isodonol, Rubescenin, NSC-250682) 是从Rabdosia rubescens中分离的对映贝壳杉烷二萜,是一种具有抗肿瘤、抗细菌和抗感染效果的传统中药。Oridonin 抑制AKT1 和 AKT2的激酶活性,对应的IC50值分别为8.4 μM 和 8.9 μM。 |
![]() ![]() Histopathological analysis of H460 tumors following combination treatment with oridonin and radiation. Hematoxylin and eosin (H-E) staining and immunohistochemistry for cleaved caspase-3 and γ-H2AX were performed on tumors harvested at 14 days after IR. Representative images of H-E-stained tumors (upper images) and cleaved caspase-3- and γ-H2AX-positive cells (middle images, brown staining) and quantification of cleaved caspase-3 and γ-H2AX-positive staining with six mice in each group (lower plots, means ± SEM) are shown; * p < 0.05.
|
|
S3810 |
ScutellarinScutellarin (Breviscapine, Breviscapin, Scutellarein-7-glucuronide)是从中草药黄芩Scutellaria baicalensis和灯盏细辛Erigeron breviscapus中提取的主要活性类黄酮,具有许多药理作用,例如抗氧化、抗肿瘤、抗病毒和抗炎活性。Scutellarin 可以下调HCC细胞中的 STAT3/Girdin/Akt 信号传导,并抑制破骨细胞中RANKL介导的 MAPK 和 NF-κB 信号通路。 |
||
S7563 |
AT13148AT13148是一种口服的,ATP竞争性的,多AGC kinase抑制剂,对Akt1/2/3,p70S6K,PKA,和ROCKI/II的IC50分别为38 nM/402 nM/50 nM,8 nM,3 nM,和6 nM/4 nM。Phase 1。 |
![]() ![]() AT13148 exerts cytotoxic and anti-proliferative activity against human gastric cancer cells. Human gastric cancer cells (HGC-27, AGS, SNU-601, N87 and MKN-28 lines) or GEC-1 gastric epithelial cells were treated with applied concentration of AT13148 for indicated time, cell survival (A and E), cell proliferation (B and F), cell cycle distribution (C, for HGC-27 cells) and cell death (D, for HGC-27 cells) were tested by the described assays, separately. Data were presented as mean ± SD. “Ctrl” stands for untreated control cells (For all figures). “hr/hrs” stands for hour/hours (For all figures). Experiments in this figure were repeated for five times. *p < 0.05 vs. “Ctrl” group.
|
|
S8132 |
DeguelinDeguelin,一种从植物中分离出来的天然产物,是PI3K/Akt的抑制剂。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S3294New |
Demethyl-CoclaurineDemethyl-Coclaurine (Higenamine, Norcoclaurine) 是中草药乌头根的关键成分,是一种 beta-2 adrenergic receptor (β2-AR) 的激动剂。Demethyl-Coclaurine 可刺激 AKT 的磷酸化,需要 PI3K 的激活才能使心肌细胞产生抗凋亡的作用。 |
||
S0765New |
MAZ51MAZ51 是一种选择性的 vascular endothelial growth factor receptor (VEGFR)-3 (Flt-4) tyrosine kinase 的有效抑制剂。MAZ51 通过 Akt/GSK3β 的磷酸化和 RhoA 的激活来诱导神经胶质瘤细胞的细胞圆缩和G2/M细胞周期停滞。 MAZ51 可抑制多种非VEGFR-3表达肿瘤细胞的增殖并诱导其凋亡。 |
||
S6760New |
LM22B-10LM22B-10 是一种小分子 TrkB/TrkC 神经营养蛋白受体共激活因子,LM22B-10 在体内和体外均可选择性地激活 TrkB、TrkC、AKT 和 ERK。 |
||
S5144 |
NeferineNeferine ((R)-1,2-Dimethoxyaporphine) 是 Nelumbo nucifera 的天然成分,具有抗肿瘤功效。Neferine 可诱导肾癌细胞凋亡。Neferine 通过激活肌肉细胞中的 Akt/mTOR 通路和 Nrf2 来防止自噬。Neferine 可抑制 NF-κB 的激活。Neferine具有多种治疗作用,例如抗糖尿病,抗衰老,抗微生物,抗血栓形成,抗心律不齐,抗炎甚至抗HIV。 |
||
S7863 |
SC79SC79是一种大脑渗透性Akt磷酸化激活剂,也是一种Akt-PH域易位抑制剂。 |
![]() ![]() Cells with OGN over-expression were challenged with EGF (100 ng/mL) and pretreated with SC79 (constitutive Akt activator) for 24 h. Western blotting with the significantly altered markers was performed.
|
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S3289New |
DaphnoretinDaphnoretin (Dephnoretin, Thymelol) 是一种从Wikstroemia indica C.A. Mey.中提取的具有生物活性的化合物,是 protein kinase C (PKC) 的激活剂。Daphnoretin 通过调节 Akt 信号通路的活性,来抑制肿瘤细胞的增殖、侵袭和迁移,促进其凋亡。 |
||
S6885New |
AilanthoneAilanthone (AIL, Δ13-Dehydrochaparrinone) 是一种来自臭椿Ailanthus altissima的天然通过抗肝癌(HCC)成分,可通过降低 cyclins 和 CDKs 的表达、提高 p21 和 p27 的表达来诱导G0/G1期细胞周期阻滞。Ailanthone 可触发DNA损伤,其特征为 ATM/ATR 通路的激活。Ailanthone 可在Huh7细胞中诱导线粒体介导、涉及 PI3K/AKT 信号通路的细胞凋亡。Ailanthone 也是全长 Androgen Receptor (AR-FL)和组成型活性截断AR剪接变体(AR-Vs, AR1-651)的抑制剂,对应的IC50值分别为69 nM和309 nM。 |
||
S8961New |
Alobresib (GS-5829)Alobresib (GS-5829) 是一种新型的 BET 抑制剂,是一种针对复发/耐药的USC过表达c-Myc的高效治疗剂。Alobresib (GS-5829) 可抑制CLL细胞增殖并通过解除如 BLK、AKT、ERK1/2和MYC等关键信号通路的管制来诱导白血病细胞凋亡apoptosis。Alobresib (GS-5829) 还可抑制 NF-κB 的信号传导。 |
||
S9514 |
Rotundic acidRotundic acid (Rutundic acid)是一种天然化合物,对人肝细胞癌(HepG2)、恶性黑色素瘤(A375)、SCLC(NCI-H446)、乳腺癌(MCF-7)和结肠癌(HT-29)细胞系表现出细胞毒活性。Rotundic acid 通过调节 AKT/mTOR and MAPK pathways 诱导细胞周期停滞、DNA损伤和细胞凋亡。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S2323 |
Methyl-HesperidinMethyl-Hesperidin 是一种在柑橘类水果中广泛存在的黄酮苷(黄酮)(C28H34O15),其苷元形式被称为橙皮素。 |